Randomized trial examines forecasting methods for expected shortfall in the Chinese market, highlighting regulatory implications.
Following the implementation of Basel IV, China’s financial regulators have replaced Value-at-Risk (VaR) with Expected Shortfall (ES) as the standard market risk measure, necessitating regulatory-oriented evaluation of ES forecasts. This study examines what constitutes a prudent ES forecasting method using e-backtesting, a sequential and model-free evaluation framework designed for regulatory monitoring. We evaluate 11 forecasting methods, including parametric, semiparametric, empirical, and deep-learning models, across four asset classes and four portfolio strategies in the Chinese market under Basel IV-consistent settings. Results show that parametric and semiparametric candidates exhibit clustered backtesting detections and increased computational burden around major market regime shifts, whereas the deep-learning model demonstrates greater resilience and produces more conservative ES forecasts during turbulent periods. These findings suggest that robustness to regime shifts should be considered a key criterion in the regulatory evaluation of ES forecasting models in the Chinese market.
No takes yet. Share an insight, caveat, or question.
Weihua Zhao (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: